Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
Tags:
patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca
Amgen Leukemia Therapy Costs $178,000, Among Priciest Drugs
Bloomberg
Wed, 12/17/14 - 04:20 pm
Tags:
drug pricing, Amgen, Blincyto, acute lymphoblastic leukemia
Amgen vet reveals stealth startup Flexus backed by $38M from Kleiner Perkins, Celgene
Fierce Biotech
Wed, 12/17/14 - 10:06 am
Tags:
Flexus, Celgene, Amgen, cancer immunotherapy
Amgen: Assessing The Split Up Value
Seeking Alpha
Tue, 12/16/14 - 11:50 pm
Tags:
Amgen
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Tags:
Novartis, Amgen, JNJ, Stelara, psoriasis, brodalumab, Cosentyx
How Amgen Makes Billions On Just A Few Drugs
Investopedia.com
Thu, 12/11/14 - 10:07 am
Tags:
Amgen
Amgen's bone drug Xgeva gets new approval
Yahoo/AP
Mon, 12/8/14 - 11:49 am
Tags:
Amgen, Xgeva, hypercalcemia of malignancy
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Mon, 12/8/14 - 10:30 am
Tags:
Agios Pharmaceuticals, Novartis, CAR-T, Celgene, Amgen, Merck, Bristol-Myers Squibb, Seattle Genetics, Sunesis
Novartis copy of Amgen biotech drug shows similar efficacy-study
Yahoo/Reuters
Mon, 12/8/14 - 08:24 am
Tags:
Novartis, Amgen, Neupogen, biosimilars, Sandoz, neutropenia
Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Yahoo/PR Newswire
Sun, 12/7/14 - 09:55 am
Tags:
Amgen, Blincyto, acute lymphoblastic leukemia, leukemia
Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
Yahoo/PR Newswire
Sat, 12/6/14 - 11:18 am
Tags:
Amgen, ONYX Pharmaceuticals, Kyprolis, Multiple Myeloma
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Tags:
Sandoz, psoriasis, Amgen, Enbrel, generics
Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning
Yahoo/Zacks.com
Fri, 12/5/14 - 08:49 am
Tags:
Amgen, Blincyto, FDA, warnings, acute lymphoblastic leukemia
FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
Yahoo/AP
Wed, 12/3/14 - 09:18 pm
Tags:
FDA, Amgen, Blincyto, B-cell acute lymphoblastic leukemia
Meet 5 Top Drug Stocks That Are Bolting Past Market
Investors.com
Tue, 12/2/14 - 08:42 am
Tags:
Celgene, Amgen, AstraZeneca, Hospira, Amag Pharmaceuticals
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wed, 11/26/14 - 11:38 am
Tags:
Amgen, AstraZeneca, brodalumab, JNJ, Stelara, psoriasis
Amgen scraps trials of drug for advanced stomach cancer
Yahoo/Reuters
Mon, 11/24/14 - 10:15 am
Tags:
Amgen, stomach cancer, rilotumumab
US biotech giant Amgen opens $200m plant in Tuas
Asia One, Singapore
Sun, 11/23/14 - 10:21 am
Tags:
Amgen, Asia
Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen
Barron's
Mon, 11/17/14 - 04:03 pm
Tags:
Merck, Vytorin, Amgen, Regeneron
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Reuters
Thu, 11/13/14 - 11:29 am
Tags:
Humira, Amgen, biosimilars

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.